History
History of the Kentucky Spinal Cord Injury Research Center
The KSCIRC was officially granted Center status by the UofL Board of Trustees in May of 2001.
The roots of the KSCIRC began as a collaboration between Dr. Shields
and John Johnson, M.D., now Professor and Chairman of Orthopedic
Surgery. In 1988, they established a joint Spine Research Laboratory
with the goal to examine basic science issues for treating the injured
spine and spinal cord. In the early 1990's, they joined forces with
other chairs, including Fred J. Roisen, Ph.D., Professor and Chairman
of Anatomical Sciences and Neurobiology, to support the growth of
neuroscience research at the UofL. An internal planning process led
the UofL to make Neuroscience one of its five areas of research
excellence, which enabled Neuroscience to undergo its active expansion.
The other areas were Birth Defects, Cardiovascular Disease, Oncology,
and Genetics & Molecular Medicine.
Two
important new funding sources accelerated this growth and focused it
increasingly in the central nervous system (CNS) area. In 1994, the
Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) was
established. This trust, funded by surcharges on Kentucky traffic
tickets, was initially used to fund grants at the UofL and the
University of Kentucky in the areas of spinal cord injury (SCI) and
head injury. At this time, Dr. Shields began adding research expertise
to his department by recruiting two faculty with strong research
interests in CNS injury, Dante J. Morassutti, M.D., and David S.K.
Magnuson, Ph.D.. Then in 1995, the UofL obtained a 5 year, $2.6M NSF
EPSCoR grant to build infrastructure in support of developmental
neurobiology. This enabled the UofL to accelerate its recruiting and
support of faculty whose research focused on various aspects of CNS
development, injury, plasticity, and/or regeneration. In the
Department of Anatomical Sciences & Neurobiology, Drs. Matthew Qiu,
Martha Bickford, Nobuyuki Kuwabara, and Brett Schofield have all been
hired over the last 5 years.
Subsequently the KSCHIRT instituted a program to fund endowments at the UofL and the University of Kentucky to assist in the growth of human capital and infrastructure. This funding, which required matching dollars, spawned a truly unique partnership between the UofL and Norton HealthCare who joined together to match those funds, leveraging the KSCHIRT funding with private donations (Norton HealthCare) and "Bucks for Brains" (UofL). "Bucks for Brains" is a unique program, instituted by Kentucky's Governor, Paul Patton, which uses a portion of the Commonwealth's budget surplus to fund research initiatives at the Universities of Louisville and Kentucky. UofL now has four and will have six endowed chairs in SCI and repair by 2003.
Dr. Whittemore joined the faculty in September of 1998 as the Henry D. Garretson Endowed Chair. At the same time, Stephen M. Onifer, Ph.D., a colleague of Dr. Whittemore's in Miami with expertise in sensory and motor system regeneration after cervical SCI was also recruited to join the Neurological Surgery faculty as an Assistant Professor. In addition to supporting the Garretson Chair, KSCHIRT, Norton HealthCare, the "Bucks for Brains" funds, and the UofL have enabled Dr. Shields and Dr. Whittemore to recruit additional scientists. Xiao Ming Xu, M.D., Ph.D. was recruited in June 2001 to fill the James R. Petersdorf Endowed Chair and is Associate Professor of Neurological Surgery. His laboratory adds further excellence in the area of SCI, Schwann cells, and regeneration. In October 2001, Theo Hagg, M.D., Ph.D., an internationally recognized researcher in the field of CNS injury and repair, was recruited as Professor of Neurological Surgery to fill an Anonymous Endowed Chair. In October of 2002 Assistant Professor Michal Hetman, M.D., Ph.D., was recruited as an Endowed Chair in Molecular Neurosignaling, sponsored by the Department of Neurological Surgery. Dr. Hetman has dual appointments; one in the Department of Neurological Surgery and one in Pharmacology and Toxicology. His expertise is in the field of Neuronal Cell Death and Neuronal Signal Transduction.

